万维提示：
1、该刊只有国际刊号。
2、投稿方式：官网投稿。
3、官网网址（微信公众号信息）：
https://journals.lww.com/cares/pages/default.aspx
4、投稿系统：
https://www.editorialmanager.com/cares/default.aspx
5、官网邮箱：CR@pub.hep.cn
6、出刊日期：季刊，一年出版四期。
7、官网信息：目前不收版面费。
8、官方微信公众号：CR2025（主办单位微信公众号信息）
2025年11月19日星期三
Cardiac Research征稿启事
【官方微信公众号信息】
CR2025 2025年2月27日
期刊简介
Cardiac Research是一本专注于心血管领域研究的国际学术期刊，旨在发表高质量的心血管基础研究、临床研究以及转化医学相关的原创性研究成果。期刊内容涵盖心血管疾病的基础机制、诊断技术、治疗策略以及疾病预防等多个方面，包括但不限于心血管疾病的基础研究、临床与流行病学研究、遗传与生物信息学研究、影像学研究、转化医学及交叉学科研究等，致力于推动心血管医学的发展和创新。
Cardiac Research围绕多个前沿领域展开征稿，优先发表以下主题：
01心血管疾病流行病学
疾病负担的时空分布
社会经济影响评估
风险因素归因分析
医疗资源利用研究
疾病预测模型
02心血管医学的治疗创新
心血管疾病发病机制的新靶点
创新药物研发与评估
医疗器械技术的优化研究
个性化治疗方案的探索
03临床研究与心血管循证医学
随机对照试验的设计与实施
系统评价与荟萃分析
真实世界证据研究
临床决策分析
预后研究
04心血管研究的方法学创新
新型生物信息学工具的应用
人工智能与机器学习
实验技术的优化与标准化
临床研究的创新分析方法
05心血管疾病的早期预防
生物标志物研究
遗传风险评估
早期筛查策略
预防医学研究
06高血压与血管疾病研究
致病靶点及机制研究
靶器官损伤研究
治疗策略优化
07心血管康复与二级预防
康复策略优化
生活方式干预研究
心理康复
长期预后评估
08心血管医学指南与临床实践
心血管疾病诊疗指南的发布与解读
Cardiac Research坚持“心起点、新视野”的办刊理念，为全球心血管研究者提供一个高水平的学术交流平台，促进基础研究、临床实践和转化医学的深度融合，推动心血管医学的创新发展。
Instructions for Authors
【官网信息】
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.
Email: CR@pub.hep.cn
AIMS AND SCOPE
Cardiac Research is a pioneering open-access journal dedicated to advancing the field of cardiovascular science. The journal encompasses a broad spectrum of research areas, including fundamental molecular discoveries, genetic and genomic investigations, advanced imaging technologies, translational research, clinical trials, and epidemiological studies in cardiovascular diseases. Our mission is to publish cutting-edge research that enhances our understanding of cardiovascular physiology and pathology, while fostering innovations in preventive strategies and therapeutic interventions. Through a rigorous peer-review and editorial process, we maintain the highest standards of scientific integrity and academic excellence.
ONLINE SUBMISSION
First-time Users
Please click the Register button at https://www.editorialmanager.com/cares/default.aspx. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference.
Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.
Authors
Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.
JOURNAL POLICIES Duplicate Publication Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Cardiac Research and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in the Cardiac Research to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript.
All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest" and "Source of Funding".
For example: "Conflicts of Interest: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared."
"Source of Funding": list all the grant supports/funders for the study.
A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.
The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: http://www.icmje.org/conflicts-of-interest.
Studies in Humans and Animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Authors describing studies involving animals must have consulted the ' Animal Research: Reporting In Vivo Experiments' (ARRIVE) 2.0 guidelines, developed by the NC3Rs to improve standards of reporting, ensuring that the data from animal experiments can be fully scrutinized and utilized. Articles reporting in vivo experiments must adhere to the ARRIVE Essential 10 checklist as a minimum, and we encourage authors to use the full ARRIVE 2.0 checklist. The relevant information outlined in these guidelines should be included in the appropriate section of the article.
Ethics
When reporting studies on human subjects, author should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Declaration of Helsinki ( https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ ). For prospective studies involving human participants, authors are expected to mention about approval of regional/national/institutional or independent ethics committee or review board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local ethics committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the ARRIVE and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving experimental animals and human beings, respectively. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the "Methods" section.
We reserve the right to decline publication of a paper even after it has been accepted if it becomes apparent that there are serious problems with the scientific content or violations of our publishing policies.
Protection of Patients' Rights to Privacy
Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives written informed consent for publication. Authors should remove patients' names from figures unless they have obtained written informed consent from the patients. The journal abides by ICMJE guidelines: (1) Authors, not the journals nor the publisher, need to have the patient consent form before the publication related to patient privacy and have the form properly archived by the author. (2) If the publication includes some facial images that make the patients identifiable, a statement about the patient's consent needs to be present in the manuscript.
Data Availability Statement
Cardiac Research requires authors to include in any articles that report results derived from research data to include a Data Availability Statement. The provision of a Data Availability Statement will be verified as a condition of publication. Data Availability Statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. Where research data are not publicly available, this must be stated in the manuscript along with any conditions for accessing the data. Data Availability Statements must take one of the following forms (or a combination of more than one if required for multiple types of research data):
The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
All data generated or analyzed during this study are included in this published article [and its supplementary information files].
The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].
AUTHORSHIP
Cardiac Researchexpects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author's specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:
Participated in research design
Participated in the writing or critical revision of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.
Authors are fully responsible for the content of their manuscript, even those parts produced by GenAI. Authors who have used GenAI in their research and the writing of manuscripts should provide an open, transparent, and detailed description of the use of GenAI (including the name and version of the GenAI tool, when it was used, how it was used, and the process of using it, and, if necessary, annotations for AI-assisted contents dealing with facts and opinions), and review of GenAI, following the body of the text, before the references, or in the method section (e.g., the authors have reviewed and edited the GenAI-produced content, and take full responsibility for the authenticity and accuracy of the content of this paper). It is recommended that authors submit and archive the GenAI-assisted sections (text, figures, programs, etc.) as supplementary material so that reviewers and editors can judge the accuracy, integrity，and originality of the paper.
Since GenAI cannot meet the requirements for authorship as they cannot take responsibility for the submitted work, GenAI -related products and developing teams cannot be listed as the author of a paper.
GenAI cannot be used to write an entire paper or a significant portion of a paper (e.g., method, result and analysis, etc.). All content that falls under the category of scientific contribution or intellectual labor should be finished by the author. If the main content of the paper is completed using GenAI, the editorial office will handle it as academic misconduct.
......
更多详情：
https://journals.lww.com/cares/Pages/informationforauthors.aspx
